Alkermes Celebrates National Women's Health Week by Reminding You Why Regular Cancer Screenings Are Vital

Alkermes Celebrates National Women's Health Week by Reminding You Why Regular Cancer Screenings Are Vital

Friday, May 13, 2022 - 10:15am

CAMPAIGN: Alkermes Medicines & Focus: Cancer

CONTENT: Multimedia with summary

This National Women’s Health Week, Alkermes’ Director of Corporate and R&D Communications, Gretchen Murphy, shares her personal story and why regular cancer screenings are vital. This NWHW, we encourage all women to learn more about early cancer detection and screenings: https://bit.ly/37zpfGm

About Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.